Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic …

PC Evans, GE Rainger, JC Mason… - Cardiovascular …, 2020 - academic.oup.com
The COVID-19 pandemic is an unprecedented healthcare emergency causing mortality and
illness across the world. Although primarily affecting the lungs, the SARS-CoV-2 virus also …

Biomechanical factors in atherosclerosis: mechanisms and clinical implications

BR Kwak, M Bäck, ML Bochaton-Piallat… - European heart …, 2014 - academic.oup.com
Blood vessels are exposed to multiple mechanical forces that are exerted on the vessel wall
(radial, circumferential and longitudinal forces) or on the endothelial surface (shear stress) …

Microvesicles in vascular homeostasis and diseases

VC Ridger, CM Boulanger… - Thrombosis and …, 2017 - thieme-connect.com
Microvesicles are members of the family of extracellular vesicles shed from the plasma
membrane of activated or apoptotic cells. Microvesicles were initially characterised by their …

[HTML][HTML] Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium

L Timmers, SK Lim, F Arslan, JS Armstrong, IE Hoefer… - Stem cell …, 2008 - Elsevier
Although paracrine effects of mesenchymal stem cells (MSCs) have been suggested
previously, cardioprotection by human MSC secretions has never been demonstrated …

Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury

L Timmers, JPS Henriques, DPV de Kleijn… - Journal of the American …, 2009 - jacc.org
Objectives: This study sought to examine whether exenatide is capable of reducing
myocardial infarct size. Background: Exenatide is a glucagon-like peptide (GLP)-1 analogue …

[HTML][HTML] Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction

L Timmers, SK Lim, IE Hoefer, F Arslan, RC Lai… - Stem cell …, 2011 - Elsevier
Recent studies suggest that the therapeutic effects of stem cell transplantation following
myocardial infarction (MI) are mediated by paracrine factors. One of the main goals in the …

Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti–toll-like receptor-2 …

F Arslan, MB Smeets, LAJ O'Neill, B Keogh, P McGuirk… - Circulation, 2010 - Am Heart Assoc
Background—Reperfusion therapy for myocardial infarction is hampered by detrimental
inflammatory responses partly via Toll-like receptor (TLR) activation. Targeting TLR …

Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction

L Timmers, JPG Sluijter, JK van Keulen… - Circulation …, 2008 - Am Heart Assoc
Left ventricular (LV) remodeling leads to congestive heart failure and is a main determinant
of morbidity and mortality following myocardial infarction. Therapeutic options to prevent LV …

The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction

GPJ Van Hout, L Bosch, GHJM Ellenbroek… - European heart …, 2017 - academic.oup.com
Aims Myocardial infarction (MI) triggers an intense inflammatory response that is associated
with infarct expansion and is detrimental for cardiac function. Interleukin (IL)-1β and IL-18 …

[PDF][PDF] Swarm intelligence-enhanced detection of non-small-cell lung cancer using tumor-educated platelets

MG Best, N Sol, S GJG, A Vancura, M Muller… - Cancer cell, 2017 - cell.com
Blood-based liquid biopsies, including tumor-educated blood platelets (TEPs), have
emerged as promising biomarker sources for non-invasive detection of cancer. Here we …